FDA unveils report to advance regulatory science

The U.S. Food and Drug Administration today unveiled a report outlining the agency's plans to advance regulatory science through its Regulatory Science Initiatie.
 
Regulatory science is the science of developing new tools, standards and approaches for assessing the safety, efficacy, quality and performance of FDA-regulated products.
 
The report provides examples of current FDA activities in regulatory science and also considers how advancements in the field can help deliver better, safer, more innovative products to Americans in seven different public health areas.
 
Copies of the report will be released at the National Press Club in Washington, D.C., when FDA Commissioner Margaret A. Hamburg M.D. speaks to a club luncheon.

Source:  U.S. Food and Drug Administration